May & Baker Nigeria plc Stock

Equities

MAYBAKER

NGMAYBAKER01

Pharmaceuticals

End-of-day quote Nigerian S.E. 06:00:00 2024-06-05 pm EDT 5-day change 1st Jan Change
6.03 NGN -10.00% Intraday chart for May & Baker Nigeria plc -10.00% +14.86%
Sales 2022 14.33B 9.7M Sales 2023 19.7B 13.33M Capitalization 9.06B 6.13M
Net income 2022 1.49B 1.01M Net income 2023 1.08B 733K EV / Sales 2022 0.7 x
Net Debt 2022 2.65B 1.8M Net Debt 2023 3.33B 2.25M EV / Sales 2023 0.63 x
P/E ratio 2022
4.98 x
P/E ratio 2023
8.36 x
Employees 376
Yield 2022
6.98%
Yield 2023
-
Free-Float 34.71%
More Fundamentals * Assessed data
Dynamic Chart
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Nigeria is working on COVID-19 vaccine, president says RE
May & Baker Nigeria plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
May & Baker Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
More news
1 day-10.00%
1 week-10.00%
Current month-10.00%
1 month+0.50%
3 months+18.70%
6 months+17.09%
Current year+14.86%
More quotes
1 week
6.03
Extreme 6.03
6.70
1 month
6.03
Extreme 6.03
7.00
Current year
4.75
Extreme 4.75
8.50
1 year
4.50
Extreme 4.5
8.50
3 years
3.35
Extreme 3.35
8.50
5 years
1.79
Extreme 1.79
8.50
10 years
0.80
Extreme 0.8
8.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 20-10-31
Director of Finance/CFO - 13-12-31
Compliance Officer - -
Members of the board TitleAgeSince
- -
Director/Board Member - 13-03-13
Director of Finance/CFO - 13-12-31
More insiders
Date Price Change Volume
24-06-06 6.03 -10.00% 226,514
24-06-05 6.7 0.00% 118,321
24-06-04 6.7 0.00% 18,661
24-06-03 6.7 0.00% 77,968
24-05-31 6.7 0.00% 283,673

End-of-day quote Nigerian S.E., June 05, 2024

More quotes
May and Baker Nigeria Plc is a diversified group organized around 2 areas of activity: - manufacturing of pharmaceutical products and vaccines (99.8% of net sales); - manufacturing and distribution of mineral water (0.2%): Lily brand. All net sales are earned in Nigeria.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.03 NGN
Average target price
7.8 NGN
Spread / Average Target
+29.35%
Consensus
  1. Stock Market
  2. Equities
  3. MAYBAKER Stock